跳至主要内容
临床试验/NCT05738005
NCT05738005招募中不适用

DRITA Pilot Trial: Dietary Reporting in the Amyloidoses

Barbara Ann Karmanos Cancer Institute2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年3月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Adherence Rate

研究概览

简要总结

The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.

The main question it aims to answer is:

Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients

Participants will be asked to:

  • Download the MyFitnessPal application on their smartphone and view an online tutorial
  • After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone.
  • complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Diagnosed with any type of amyloidosis
  • Speak, read and write in English
  • Willing to use the MyFitnessPal app on their own smartphone

排除标准

  • a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
  • cognitive or perceptual disturbances

研究组 & 干预措施

Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)

Other

MyFitnessPal smartphone application is used to track daily dietary intake and herbal/alternative supplements.

干预措施: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) (Other)

结局指标

主要结局

Adherence Rate

时间窗: 56 days

The adherence is defined by the status (yes vs. no) of data recording per day; The adherence rate will be calculated by the ratio of the number of days of adherence to the total number of days of trial (i.e., 56 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.

次要结局

  • Subsequent adherence rate(63 days (= 56 days + Week 10))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey Zonder

Principal Investigator, Multiple Myeloma Multidisciplinary team leader, M.D.

Barbara Ann Karmanos Cancer Institute

研究点 (2)

Loading locations...

相似试验